ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

UFPT vs JNJ // GROSS PROFIT MARGIN

UFP Technologies Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: UFPT 4 — JNJ 8
▲ GROSS PROFIT MARGIN LEADER: JNJ
gross-margins
67.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UFPT VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC UFPT JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE 28.30% 67.90% -39.60 JNJ /gross-margins <GO>
Return on Invested Capital (ROIC) 13.90% 25.50% -11.60 JNJ /roic <GO>
EV/EBITDA & P/E Valuation 25.7x 18.5x +7.20 JNJ /valuation <GO>
Free Cash Flow Yield 4.05% 2.97% +1.08 UFPT /fcf-yield <GO>
Operating Margin 15.30% 34.70% -19.40 JNJ /operating-margins <GO>
Net Profit Margin 11.30% 28.50% -17.20 JNJ /net-margins <GO>
Revenue Growth (YoY) 19.50% 6.00% +13.50 UFPT /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 8.31 5.59 +2.72 UFPT /balance-sheet <GO>
Piotroski F-Score Quality 9/9 8/9 +1.00 UFPT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.0 62.1 -18.06 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.08 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 28.0x 23.0x +5.00 JNJ /forward-pe <GO>
Enterprise Scale & Market Cap $2.27B $662.49B -$660.22B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR UFPT REV JNJ REV UFPT GROSS % JNJ GROSS % UFPT FCF JNJ FCF
FY 2025 $602.8M $94.19B 28.3% 67.9% $91.9M $19.70B
FY 2024 $504.4M $88.82B 29.1% 69.1% $56.9M $19.84B
FY 2023 $400.1M $85.16B — — $41.3M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UFPT // BETA —
JNJ // BETA 1.08